Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine. Visit www.singulargenomics.com for more information. Media Contact Darius Fugere ...

SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC) (“Singular Genomics” or the “Company”), a company leveraging novel next-generation sequencing ...

Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4® Sequencing Platform is a powerful ...

SAN DIEGO, July 30, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to ...

SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to ...

Singular Genomics has unveiled an upgrade to its G4 Sequencing Platform—the G4X™ Spatial Sequencer, a high-throughput in situ spatial sequencing platform designed for simultaneous direct RNA ...

--Singular Genomics Systems, Inc., a company leveraging novel next-generation sequencing and spatial multiomics technologies to empower researchers and clinicians, today unveiled the G4X ...

Investor Contact Matt Clawson 949-370-8500 [email protected] Media Contact Dan Budwick, 1AB973-271-6085 [email protected] Source: Singular Genomics Systems, Inc. Subscribe Now -> ...

In addition, the company is currently developing the G4X™ Spatial Sequencer, an upgrade to the G4, which will leverage Singular’s proprietary sequencing technology, applying it as an in situ ...

SAN DIEGO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to ...